Cigna (CI) to Buy Arcadian, Humana Medicare Advantage Plans in Texas, Arkansas
Tweet
Share
E-mailGet Alerts CI Hot Sheet
Price: $280.97 -1.27%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
Revenue Growth %: +23.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
Revenue Growth %: +23.5%
Join SI Premium – FREE
Cigna (NYSE: CI) today announced that it has come to an agreement with Humana to purchase select Medicare Advantage plans in Texas and Arkansas. The plans in the three markets – Amarillo, Longview-Marshall and Texarkana – are part of a previously announced government-stipulated divestiture for Humana to complete its acquisition of Arcadian Health.
Effective January 1, 2013, the approximately 3,500 Humana or Arcadian members impacted by the divestiture will join more than one million customers who access HealthSpring’s physician engagement model that works collaboratively with doctors to provide access to high quality, coordinated care that is focused on prevention and total body wellness.
Effective January 1, 2013, the approximately 3,500 Humana or Arcadian members impacted by the divestiture will join more than one million customers who access HealthSpring’s physician engagement model that works collaboratively with doctors to provide access to high quality, coordinated care that is focused on prevention and total body wellness.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rio Tinto (RIO), Glencore Said to Discuss Potential Combination - Bloomberg
- Symbotic (SYM) to Acquire Walmart’s (WMT) Advanced Systems and Robotics Business and Sign Related Commercial Agreement
- Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
